Zinc in PDB 2eci: Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein
Zinc Binding Sites:
The binding sites of Zinc atom in the Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein
(pdb code 2eci). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein, PDB code: 2eci:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 2eci
Go back to
Zinc Binding Sites List in 2eci
Zinc binding site 1 out
of 2 in the Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn201
b:0.0
occ:1.00
|
SG
|
A:CYS51
|
2.2
|
0.0
|
1.0
|
SG
|
A:CYS31
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS48
|
2.4
|
0.0
|
1.0
|
SG
|
A:CYS28
|
2.4
|
0.0
|
1.0
|
HB2
|
A:CYS48
|
2.9
|
0.0
|
1.0
|
HB3
|
A:CYS31
|
3.0
|
0.0
|
1.0
|
H
|
A:CYS31
|
3.1
|
0.0
|
1.0
|
HB3
|
A:CYS28
|
3.1
|
0.0
|
1.0
|
HB2
|
A:CYS51
|
3.2
|
0.0
|
1.0
|
CB
|
A:CYS28
|
3.2
|
0.0
|
1.0
|
CB
|
A:CYS48
|
3.2
|
0.0
|
1.0
|
CB
|
A:CYS51
|
3.3
|
0.0
|
1.0
|
CB
|
A:CYS31
|
3.3
|
0.0
|
1.0
|
HB2
|
A:CYS28
|
3.3
|
0.0
|
1.0
|
H
|
A:CYS48
|
3.4
|
0.0
|
1.0
|
HB
|
A:ILE30
|
3.4
|
0.0
|
1.0
|
HB3
|
A:CYS51
|
3.6
|
0.0
|
1.0
|
N
|
A:CYS31
|
3.8
|
0.0
|
1.0
|
HB3
|
A:CYS48
|
4.0
|
0.0
|
1.0
|
N
|
A:CYS48
|
4.1
|
0.0
|
1.0
|
HB2
|
A:CYS31
|
4.1
|
0.0
|
1.0
|
CA
|
A:CYS31
|
4.2
|
0.0
|
1.0
|
CA
|
A:CYS48
|
4.3
|
0.0
|
1.0
|
H
|
A:CYS51
|
4.4
|
0.0
|
1.0
|
HD12
|
A:ILE30
|
4.4
|
0.0
|
1.0
|
CB
|
A:ILE30
|
4.5
|
0.0
|
1.0
|
HD23
|
A:LEU35
|
4.5
|
0.0
|
1.0
|
HA
|
A:LEU35
|
4.5
|
0.0
|
1.0
|
H
|
A:ILE30
|
4.6
|
0.0
|
1.0
|
HG23
|
A:ILE30
|
4.6
|
0.0
|
1.0
|
CA
|
A:CYS51
|
4.6
|
0.0
|
1.0
|
H
|
A:ARG36
|
4.6
|
0.0
|
1.0
|
CA
|
A:CYS28
|
4.7
|
0.0
|
1.0
|
H
|
A:LEU32
|
4.7
|
0.0
|
1.0
|
HG3
|
A:MET33
|
4.7
|
0.0
|
1.0
|
HG2
|
A:MET33
|
4.8
|
0.0
|
1.0
|
C
|
A:ILE30
|
4.9
|
0.0
|
1.0
|
HG22
|
A:ILE30
|
4.9
|
0.0
|
1.0
|
CG2
|
A:ILE30
|
4.9
|
0.0
|
1.0
|
HB3
|
A:PHE47
|
4.9
|
0.0
|
1.0
|
HA
|
A:PHE47
|
4.9
|
0.0
|
1.0
|
N
|
A:CYS51
|
4.9
|
0.0
|
1.0
|
HA
|
A:CYS51
|
5.0
|
0.0
|
1.0
|
HA
|
A:CYS31
|
5.0
|
0.0
|
1.0
|
HA
|
A:CYS48
|
5.0
|
0.0
|
1.0
|
H
|
A:MET33
|
5.0
|
0.0
|
1.0
|
|
Zinc binding site 2 out
of 2 in 2eci
Go back to
Zinc Binding Sites List in 2eci
Zinc binding site 2 out
of 2 in the Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn401
b:0.0
occ:1.00
|
OD2
|
A:ASP66
|
2.0
|
0.0
|
1.0
|
ND1
|
A:HIS45
|
2.0
|
0.0
|
1.0
|
SG
|
A:CYS63
|
2.2
|
0.0
|
1.0
|
SG
|
A:CYS43
|
2.2
|
0.0
|
1.0
|
HB2
|
A:HIS45
|
2.9
|
0.0
|
1.0
|
CE1
|
A:HIS45
|
2.9
|
0.0
|
1.0
|
HG22
|
A:VAL65
|
2.9
|
0.0
|
1.0
|
CG
|
A:ASP66
|
3.0
|
0.0
|
1.0
|
HE1
|
A:HIS45
|
3.1
|
0.0
|
1.0
|
CG
|
A:HIS45
|
3.1
|
0.0
|
1.0
|
HG23
|
A:VAL65
|
3.3
|
0.0
|
1.0
|
OD1
|
A:ASP66
|
3.3
|
0.0
|
1.0
|
HZ
|
A:PHE47
|
3.3
|
0.0
|
1.0
|
HB2
|
A:CYS43
|
3.4
|
0.0
|
1.0
|
CG2
|
A:VAL65
|
3.4
|
0.0
|
1.0
|
CB
|
A:CYS43
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS63
|
3.5
|
0.0
|
1.0
|
CB
|
A:HIS45
|
3.5
|
0.0
|
1.0
|
HG21
|
A:VAL65
|
3.5
|
0.0
|
1.0
|
HB2
|
A:CYS63
|
3.6
|
0.0
|
1.0
|
HE2
|
A:PHE47
|
3.7
|
0.0
|
1.0
|
HB3
|
A:CYS63
|
3.8
|
0.0
|
1.0
|
HG1
|
A:THR41
|
3.9
|
0.0
|
1.0
|
H
|
A:ASP66
|
4.0
|
0.0
|
1.0
|
NE2
|
A:HIS45
|
4.1
|
0.0
|
1.0
|
HB3
|
A:CYS43
|
4.1
|
0.0
|
1.0
|
CD2
|
A:HIS45
|
4.2
|
0.0
|
1.0
|
CZ
|
A:PHE47
|
4.2
|
0.0
|
1.0
|
HB3
|
A:HIS45
|
4.2
|
0.0
|
1.0
|
H
|
A:GLY44
|
4.3
|
0.0
|
1.0
|
CB
|
A:ASP66
|
4.3
|
0.0
|
1.0
|
CE2
|
A:PHE47
|
4.4
|
0.0
|
1.0
|
N
|
A:GLY44
|
4.4
|
0.0
|
1.0
|
N
|
A:HIS45
|
4.4
|
0.0
|
1.0
|
HB3
|
A:ASP66
|
4.4
|
0.0
|
1.0
|
C
|
A:GLY44
|
4.4
|
0.0
|
1.0
|
HD2
|
A:PRO64
|
4.5
|
0.0
|
1.0
|
C
|
A:CYS43
|
4.6
|
0.0
|
1.0
|
OG1
|
A:THR41
|
4.6
|
0.0
|
1.0
|
O
|
A:GLY44
|
4.6
|
0.0
|
1.0
|
CA
|
A:HIS45
|
4.6
|
0.0
|
1.0
|
N
|
A:ASP66
|
4.6
|
0.0
|
1.0
|
CA
|
A:CYS43
|
4.7
|
0.0
|
1.0
|
H
|
A:HIS45
|
4.7
|
0.0
|
1.0
|
HB2
|
A:GLU68
|
4.7
|
0.0
|
1.0
|
H
|
A:VAL65
|
4.7
|
0.0
|
1.0
|
CA
|
A:CYS63
|
4.8
|
0.0
|
1.0
|
CB
|
A:VAL65
|
4.9
|
0.0
|
1.0
|
HE2
|
A:HIS45
|
4.9
|
0.0
|
1.0
|
HA
|
A:CYS63
|
4.9
|
0.0
|
1.0
|
CA
|
A:GLY44
|
4.9
|
0.0
|
1.0
|
HB
|
A:THR41
|
5.0
|
0.0
|
1.0
|
|
Reference:
K.Miyamoto,
M.Sato,
S.Koshiba,
S.Watanabe,
T.Harada,
T.Kigawa,
S.Yokoyama.
Solution Structure of the Ring Domain of the Human Tnf Receptor-Associated Factor 6 Protein To Be Published.
Page generated: Wed Oct 16 23:03:59 2024
|